Weifeng Yao

2.9k total citations · 1 hit paper
101 papers, 2.3k citations indexed

About

Weifeng Yao is a scholar working on Surgery, Molecular Biology and Hepatology. According to data from OpenAlex, Weifeng Yao has authored 101 papers receiving a total of 2.3k indexed citations (citations by other indexed papers that have themselves been cited), including 36 papers in Surgery, 31 papers in Molecular Biology and 18 papers in Hepatology. Recurrent topics in Weifeng Yao's work include Organ Transplantation Techniques and Outcomes (18 papers), Liver Disease and Transplantation (13 papers) and Cardiac Ischemia and Reperfusion (11 papers). Weifeng Yao is often cited by papers focused on Organ Transplantation Techniques and Outcomes (18 papers), Liver Disease and Transplantation (13 papers) and Cardiac Ischemia and Reperfusion (11 papers). Weifeng Yao collaborates with scholars based in China, Hong Kong and United States. Weifeng Yao's co-authors include Ziqing Hei, Zhengyuan Xia, Haobo Li, Dongdong Yuan, Chaojin Chen, Mian Ge, Xinjin Chi, Jun Cai, Shaoli Zhou and Yihan Zhang and has published in prestigious journals such as ACS Nano, Biomaterials and Diabetes.

In The Last Decade

Weifeng Yao

97 papers receiving 2.3k citations

Hit Papers

A Supervised Explainable Machine Learning Model for Perio... 2025 2026 2025 4 8 12

Peers

Weifeng Yao
Leilei Ma China
Ping Xie China
H. Thomas Lee United States
Weifeng Yao
Citations per year, relative to Weifeng Yao Weifeng Yao (= 1×) peers Meng‐Yu Wu

Countries citing papers authored by Weifeng Yao

Since Specialization
Citations

This map shows the geographic impact of Weifeng Yao's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Weifeng Yao with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Weifeng Yao more than expected).

Fields of papers citing papers by Weifeng Yao

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Weifeng Yao. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Weifeng Yao. The network helps show where Weifeng Yao may publish in the future.

Co-authorship network of co-authors of Weifeng Yao

This figure shows the co-authorship network connecting the top 25 collaborators of Weifeng Yao. A scholar is included among the top collaborators of Weifeng Yao based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Weifeng Yao. Weifeng Yao is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Ding, Zhendong, Linan Zhang, Yihan Zhang, et al.. (2025). A Supervised Explainable Machine Learning Model for Perioperative Neurocognitive Disorder in Liver-Transplantation Patients and External Validation on the Medical Information Mart for Intensive Care IV Database: Retrospective Study. Journal of Medical Internet Research. 27. e55046–e55046. 12 indexed citations breakdown →
2.
Wang, Wenhao, Yi Zhang, Beihua Bao, et al.. (2024). Roles of nanomaterials in thrombin detection. TrAC Trends in Analytical Chemistry. 175. 117734–117734. 8 indexed citations
3.
Yao, Weifeng, et al.. (2024). Towards precision medicine: design considerations for nanozymes in tumor treatment. Journal of Translational Medicine. 22(1). 1033–1033. 5 indexed citations
4.
Duan, Zhiyong, Zhiren Lu, Lei Shen, et al.. (2023). The prognostic value and economic benefits of coronary angiography-derived fractional flow reserve-guided strategy in patients with coronary artery disease. Heliyon. 9(6). e17464–e17464. 2 indexed citations
5.
Yang, Jing, Chaojin Chen, Tienan Wang, et al.. (2023). Injury Site Specific Xenon Delivered by Platelet Membrane‐Mimicking Hybrid Microbubbles to Protect Against Acute Kidney Injury via Inhibition of Cellular Senescence. Advanced Healthcare Materials. 12(20). e2203359–e2203359. 6 indexed citations
6.
Li, Junying, et al.. (2023). Analysis and Characterization of the Facial Skin Microbiota in Rosacea. Jundishapur Journal of Microbiology. 16(2). 1 indexed citations
7.
Diao, Yong‐Kang, Yi Zhang, Ying Shi, et al.. (2022). Bioinformatic analysis of FOXN3 expression and prognostic value in pancreatic cancer. Frontiers in Oncology. 12. 1008100–1008100. 3 indexed citations
8.
Lu, Wenfeng, Dongdong Wang, Zunqiang Xiao, et al.. (2022). Impact of metabolic syndrome on the long-term prognosis of patients with hepatitis B virus-related hepatocellular carcinoma after hepatectomy. Frontiers in Oncology. 12. 1042869–1042869. 3 indexed citations
10.
Yang, Jing, Yu Guan, Chaojin Chen, et al.. (2021). Microbubble Functionalization with Platelet Membrane Enables Targeting and Early Detection of Sepsis‐Induced Acute Kidney Injury. Advanced Healthcare Materials. 10(23). e2101628–e2101628. 40 indexed citations
11.
Zhang, Zheng, Weifeng Yao, Dongdong Yuan, et al.. (2020). Effects of Connexin 32-Mediated Lung Inflammation Resolution During Liver Ischemia Reperfusion. Digestive Diseases and Sciences. 65(10). 2914–2924. 6 indexed citations
12.
Yao, Weifeng, Xue Han, Mian Ge, et al.. (2020). N6-methyladenosine (m6A) methylation in ischemia–reperfusion injury. Cell Death and Disease. 11(6). 478–478. 45 indexed citations
13.
Wu, Shan, Weifeng Yao, Chaojin Chen, et al.. (2020). Connexin 32 deficiency protects the liver against ischemia/reperfusion injury. European Journal of Pharmacology. 876. 173056–173056. 10 indexed citations
14.
Chen, Chaojin, Weifeng Yao, Shan Wu, et al.. (2018). Crosstalk Between Connexin32 and Mitochondrial Apoptotic Signaling Pathway Plays a Pivotal Role in Renal Ischemia Reperfusion-Induced Acute Kidney Injury. Antioxidants and Redox Signaling. 30(12). 1521–1538. 28 indexed citations
15.
Ge, Mian, Weifeng Yao, Dongdong Yuan, et al.. (2017). Brg1-mediated Nrf2/HO-1 pathway activation alleviates hepatic ischemia–reperfusion injury. Cell Death and Disease. 8(6). e2841–e2841. 140 indexed citations
16.
Xu, Junmei, Weifeng Yao, Haobo Li, et al.. (2015). Sevoflurane pretreatment attenuates TNF-α-induced human endothelial cell dysfunction through activating eNOS/NO pathway. Biochemical and Biophysical Research Communications. 460(3). 879–886. 31 indexed citations
17.
Li, Haobo, Weifeng Yao, Michael G. Irwin, et al.. (2015). Adiponectin ameliorates hyperglycemia-induced cardiac hypertrophy and dysfunction by concomitantly activating Nrf2 and Brg1. Free Radical Biology and Medicine. 84. 311–321. 91 indexed citations
18.
Ge, Mian, Gangjian Luo, Weifeng Yao, et al.. (2014). Propofol pretreatment attenuates remote kidney injury induced by orthotopic liver autotransplantation, which is correlated with the activation of Nrf2 in rats. Molecular Medicine Reports. 11(5). 3962–3968. 14 indexed citations
19.
Zhao, Weicheng, Shaoli Zhou, Weifeng Yao, et al.. (2014). Propofol prevents lung injury after intestinal ischemia–reperfusion by inhibiting the interaction between mast cell activation and oxidative stress. Life Sciences. 108(2). 80–87. 41 indexed citations
20.
Luo, Gangjian, et al.. (2014). Ulinastatin prevents acute lung injury led by liver transplantation. Journal of Surgical Research. 193(2). 841–848. 10 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026